Special Issue Virology

Comparison of the Accula SARS-CoV-2 Test with a Laboratory-Developed Assay for Detection of SARS-CoV-2 RNA in Clinical Nasopharyngeal Specimens

Catherine A. Hogan, Natasha Garamani, Andrew S. Lee, Jack K. Tung, Malaya K. Sahoo, ChunHong Huang, Bryan Stevens, James Zehnder, Benjamin A. Pinsky
Alexander J. McAdam, Editor
DOI: 10.1128/JCM.01072-20

Article Figures & Data

Figures

  • FIG 1
    FIG 1

    Images of the Accula SARS-CoV-2 lateral-flow readout. (A) Positive patient specimen; (B) negative patient specimen. C, internal positive process control; T, SARS-CoV-2 test; NC, internal negative process control.

Tables

  • TABLE 1

    Comparison of the SHC-LDT for SARS-CoV-2 and the Accula SARS-CoV-2 PCR test

    TABLE 1

    • ↵a SHC-LDT, Stanford Health Care laboratory-developed test.

  • TABLE 2

    PPA of the Accula SARS-CoV-2 PCR test compared to the SHC-LDT for SARS-CoV-2, stratified by CT values and transport medium type

    TABLE 2
Back to top
Download PDF
Citation Tools
Print

Alerts
Email

KEYWORDS

COVID-19
laboratory-developed test
Mesa Accula
point-of-care test
SARS-CoV-2

Related Articles

Cited By...